A Phase I, Single Center, Open Label, Intra Subject, Dose Escalation Study to Evaluate Safety and Tolerability of Sertraline Plus Telenzepine in Overweight Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 08 Jan 2013
At a glance
- Drugs Sertraline (Primary) ; Telenzepine (Primary)
- Indications Obesity
- Focus Adverse reactions; Therapeutic Use
- 19 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Jul 2010 New trial record